Sievers, E. L., Larson, R. A., Estey, E., Stadtmauer, E. A., Erba, H. P., Roy, D. C. C., … Appelbaum, F. R. (1999). Efficacy and safety of CMA-676 in patients with AML in first relapse. In BLOOD (Vol. 94, pp. 696A-696A). AMER SOC HEMATOLOGY.

Sievers, E. L., R. A. Larson, E. Estey, E. A. Stadtmauer, H. P. Erba, D. C. C. Roy, L. Tarantolo, et al. “Efficacy and safety of CMA-676 in patients with AML in first relapse.” In BLOOD, 94:696A-696A. AMER SOC HEMATOLOGY, 1999.

Sievers EL, Larson RA, Estey E, Stadtmauer EA, Erba HP, Roy DCC, et al. Efficacy and safety of CMA-676 in patients with AML in first relapse. In: BLOOD. AMER SOC HEMATOLOGY; 1999. p. 696A-696A.

Sievers, E. L., et al. “Efficacy and safety of CMA-676 in patients with AML in first relapse.” BLOOD, vol. 94, no. 10, AMER SOC HEMATOLOGY, 1999, pp. 696A-696A.

Sievers EL, Larson RA, Estey E, Stadtmauer EA, Erba HP, Roy DCC, Tarantolo L, Spielberger R, Berger MS, Eten C, Manley L, Stone A, Bernstein I, Appelbaum FR. Efficacy and safety of CMA-676 in patients with AML in first relapse. BLOOD. AMER SOC HEMATOLOGY; 1999. p. 696A-696A.